On air · 3 of 3 networks
Fresenius Kabi
- fresenius-kabi.com
- Healthcare & Life Sciences
- DE
- 26,001 employees
Fresenius Kabi’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 400. Watch Fresenius Kabi with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 120 | Checked 28 Oct 2026 | See all 400 ads → | ||
| Meta | Running | 9 | Active ads on the Meta Ad Library, all countries | Checked 28 Oct 2026 | Collect them with the API → |
| Running | 79 | Ads on the Google Ads Transparency Center | Checked 28 Oct 2026 | Collect them with the API → |
Fresenius Kabi has 120 live LinkedIn ads. Its Facebook page had 9 active ads on 28 Oct 2026, and we recorded 79 Google ads on 28 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 26 Oct 2026
How could a clearer understanding of nutritional needs help shape future treatment for patients in neuro-intensive care? This is what NeuroNutriTraj, the research project led by Dr. Stefano Marelli, sets out to explore. The project has been awarded the 2026 ESICM–Fresenius Kabi Medical Nutrition Grant today. The €20,000 grant will support his research project; exploring how patients’ nutritional needs may change throughout serious illness and recovery after a brain injury. By mapping nutritional status and responses over time, the project aims to generate insights that may inform future research into more personalized nutritional approaches – with the long-term goal of supporting care that better reflects each patient’s changing needs. As part of the Fresenius Group, supporting patients and healthcare professionals in advancing care through research in medical nutrition is one way we contribute to #FutureFresenius. #FreseniusCommittedToLife #FutureFresenius #LIVES2026
- LINKEDIN · IMAGESince 16 Oct 2026
After a very meaningful chapter at Fresenius Kabi, I have decided to leave the company and pursue a change in my professional life. This has been a deeply personal decision, made with enormous respect for the business, its people and everything we have achieved together. As I look back on this chapter and as someone who loves hiking, one image stays with me: no one reaches the summit alone. It is the rope team that matters. I have been fortunate to be part of an extraordinary team at Fresenius Kabi, and I leave with deep gratitude for every step we took together. I leave with a full heart and enormous appreciation for everyone who has been part of my journey at Fresenius Kabi. My thanks to Michael Sen and Wolfgang Kirsch for their trust and support over the many years. I am pleased to hand over to Marc-Alexander Mahl, who knows our business and has been an important member of our leadership team. I am confident that he will provide strong continuity for the next chapter. With gratitude.
- LINKEDIN · VIDEOSince 12 Oct 2026
We don't often think about choice until it becomes limited. Sometimes it's as simple as having a favorite. Or choosing something different because you've had the same thing too many times. These everyday decisions are part of our relationship with food, yet they're easy to overlook. For people receiving enteral nutrition via tube feeding, nutritional support comes first. But that doesn't mean personal preferences stop mattering. Available in three meal-inspired varieties, NutriChef brings a real food approach and greater choice to enteral nutrition. Inspired by patient perspectives, NutriChef reflects the Fresenius Group Principle of serving patients beyond expectations and the thinking behind #FutureFresenius. #FreseniusCommittedToLife #FutureFresenius #NutriChef #MedicalNutrition NutriChef is a food for special medical purposes for the dietary management in case/ risk of malnutrition and must be used under medical supervision. Not suitable for children <3 years. Use with caution in children <6 years.
- LINKEDIN · IMAGESince 9 Oct 2026
We have reached another milestone on our Biopharma journey. 🚀 With full ownership of mAbxience, Fresenius is strengthening its vertically integrated biosimilars platform – from development and manufacturing to commercialization. This puts us in a strong position to capture new market opportunities as demand for high-quality biosimilars continues to grow. Find out more via the link below. #FutureFresenius #FreseniusCommittedToLife
- LINKEDIN · VIDEOSince 2 Oct 2026
What does patient-centered cancer care look like? Following our satellite symposium at ESPEN Congress, Prof. Arved Weimann and Dr. Nicole Erickson reflect on key themes from this year's discussions, including multidisciplinary collaboration, nutrition care and the importance of listening to patient voices. More expert perspectives and resources from ESPEN 2026 will be available soon on nutritionevents.com. As part of Fresenius Group, our work in medical nutrition contributes to #FutureFresenius and our shared commitment to advancing patient-centered care. #FreseniusCommittedToLife #FutureFresenius #ESPEN2026 #MedicalNutrition
- LINKEDIN · IMAGESince 29 Sept 2026
What role can food still play when nutritional support becomes part of care? For many of us, food is tied to habits, preferences, and familiar meals. NutriChef was developed with that understanding. Made with real food ingredients and available in meal-inspired varieties, it brings a new approach to enteral nutrition via tube feeding. At Fresenius Kabi, part of the Fresenius Group, NutriChef was inspired by a broader view of what matters to patients, a perspective that also shapes #FutureFresenius. #FreseniusCommittedToLife #FutureFresenius #NutriChef #MedicalNutrition NutriChef is a food for special medical purposes for the dietary management in case/ risk of malnutrition and must be used under medical supervision. Not suitable for children <3 years. Use with caution in children <6 years.
6 of 400 adsSign up to see every Fresenius Kabi ad, filter by format and date, and get alerts on new ones.
See all 400 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.